Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine
Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e1335-e1340
DOI: 10.1093/cid/ciac549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.07.2022. Verfasst von Ganapathi Iyer Parameswaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Herpes Zoster Vaccine, Herpes Zoster. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Studies evaluating stroke following varicella zoster virus (VZV) infection are limited, and the utility of zoster vaccination against this phenomenon is unclear. This study aimed to determine the risk of stroke 30 days following zoster infection and to evaluate the impact of zoster vaccinations on the risk of stroke in VZV-infected patients.
Methods
This retrospective case-control study was conducted from January 2010 to January 2020 utilizing nationwide patient data retrieved from the Veterans Affairs’ Corporate Data Warehouse.
Results
A total of 2 165 505 patients ≥18 years of age who received care at a Veterans Affairs facility were included in the study, of whom 71 911 had a history of zoster infection. Zoster patients were found to have 1.9 times increased likelihood of developing a stroke within 30 days following infection (odds ratio [OR], 1.93 [95% confidence interval {CI}, 1.57–2.4]; P < .0001). A decreased risk of stroke was seen in patients who received the recombinant zoster vaccine (OR, 0.57 [95% CI, .46–.72]; P < .0001) or the live zoster vaccine (OR, 0.77 [95% CI, .65–.91]; P = .002).
Conclusions
Patients had a significantly higher risk of stroke within the first month following recent herpes zoster infection. Receipt of at least 1 zoster vaccination was found to mitigate this increased risk. Vaccination may therefore be viewed as a protective tool against the risk of neurologic postinfection sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
- Division of Infectious Diseases, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
- Department of Pharmacy, Veterans Affairs Western New York Healthcare System, Buffalo, New York, USA.
- Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA.
Zitieren
APA
Parameswaran, G. I., Wattengel, B. A., Chua, H. C., Swiderek, J., Fuchs, T., Carter, M. T., Goode, L., Doyle, K., & Mergenhagen, K. A. (2023). Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine. Clinical Infectious Diseases, 76(3), e1335-e1340. https://doi.org/10.1093/cid/ciac549
Vancouver
Parameswaran GI, Wattengel BA, Chua HC, Swiderek J, Fuchs T, Carter MT, et al. Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine. Clinical Infectious Diseases. 2023;76(3):e1335-e1340. doi:10.1093/cid/ciac549
BibTeX
@article{Parameswaran2023,
author = {Parameswaran, Ganapathi Iyer and Wattengel, Bethany A and Chua, Hubert C and Swiderek, Jessica and Fuchs, Tom and Carter, Michael T and Goode, Laura and Doyle, Kathleen and Mergenhagen, Kari A},
title = {Increased Stroke Risk Following Herpes Zoster Infection and Protection With Zoster Vaccine},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {3},
pages = {e1335--e1340},
doi = {10.1093/cid/ciac549}
}
EUVIMED